🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use — my results so far Page 2

Hypoglycemia risk with concomitant sulfonylurea use — my results so far

mike.trainer_LA Thu, Apr 4, 2024 at 5:38 PM 34 replies 2,155 viewsPage 2 of 7
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Apr 4, 2024 at 10:16 PM#6
labquiet_amy said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

32 2lucas_SP_BR, lisa_labSD, adam_van and 29 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Apr 5, 2024 at 12:05 AM#7

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

31 1JenPlateau, SallyK_inj, CryptoCarl and 28 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Apr 5, 2024 at 1:54 AM#8
Dr.SportsMedIN said:
I dislike how confidently this board tells people to push through.

Coming at Dr.SportsMedIN’s question from a different direction. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

30 0jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 27 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Apr 5, 2024 at 3:43 AM#9

Following on from julia.endo — and this may be the naive question:

Whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out?

29 24tane_welly, Dr.PathRoch, mona_PHX and 26 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Apr 5, 2024 at 12:25 PM#10

OP back with an update, since a thread like this is useless without one.

Holding the step for six weeks instead of four did it. Same dose, same food, and the nausea that had felt like a wall turned out to be a timing problem.

31 4marcus_mpls, DeniseRN_TPA, SandraNC_45 and 28 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register